🔬💉 Vaccine Breakthroughs: mRNA Settlements, Cancer Vaccine Trials, RSV Effectiveness & More
This week’s Vaccine Research roundup brings you essential updates on global vaccine breakthroughs—from major settlements in mRNA patent disputes, to innovative cancer vaccine trials, new RSV vaccine findings, and developments in pneumococcal vaccines. Stay informed and ahead of the curve with the latest insights into vaccine research and clinical innovations.
🔬 Key highlights:
đź’‰ GSK reaches a $370 million settlement over mRNA patents with BioNTech/CureVac
🦠NHS fast-tracks head and neck cancer vaccine trials in the UK
⚖️ Breakthrough in Strep A vaccine development could save over 500,000 lives annually
❌ FDA may not renew Pfizer’s pediatric COVID-19 vaccine authorization
🧊 RSV vaccination shows 82% effectiveness in preventing hospitalizations in older adults
🧪 IO Biotech’s cancer vaccine shows improvement in late-stage study with Merck’s Keytruda
🌍 Pfizer launches PCV20 pneumococcal vaccine in India
📢 Stay Ahead in Vaccine Research!
âś… Like, share, and subscribe for weekly updates on vaccine innovations and global immunization progress
#VaccineResearch #mRNA #CancerVaccine #RSVVaccine #BioTech #PublicHealth #ClinicalTrials #LucidQuest #VaccineInnovation #Pharmaceuticals #InfectiousDiseases #Healthcare #StrepA #PediatricVaccine #LucidQuestUpdates #GlobalHealth #SubscribeNow